IMMUNOLOGICAL EFFECTS OF ALTERNATIVE WEEKLY INTERFERON-ALPHA-2B AND LOW-DOSE INTERLEUKIN-2 IN PATIENTS WITH CANCER

被引：8
|
作者：
FIORENTINO, B
DISTEFANO, P
GIULIANI, C
AMATETTI, C
TINARI, N
NATOLI, C
GARUFI, C
IACOBELLI, S
机构：
[1] UNIV G DANNUNZIO, CATTEDRA ONCOL MED, VIA DEI VESTINI 66, I-66100 CHIETI, ITALY
[2] UNIV G DANNUNZIO, CATTEDRA ENDOCRINOL, I-66100 CHIETI, ITALY
来源：
BRITISH JOURNAL OF CANCER | 1992年 / 66卷 / 05期
关键词：
D O I：
10.1038/bjc.1992.396
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：981 / 983
页数：3
相关论文
共 50 条
  • [21] RECOMBINANT INTERFERON-ALPHA-2B TREATMENT OF HAIRY-CELL LEUKEMIA - EXPERIENCE WITH A LOW-DOSE SCHEDULE
    HASSELBALCH, H
    BRAIDE, I
    LISSE, I
    ROCKERT, LL
    SWOLIN, B
    CARNESKOG, J
    HAGBERG, H
    HIPPE, E
    JENSEN, MK
    LUNDIN, P
    MALM, C
    NIELSEN, B
    RODJER, S
    WESTIN, J
    ZADOR, G
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1988, 41 (05) : 438 - 444
  • [22] LOW-DOSE RECOMBINANT INTERLEUKIN-2 AND LOW-DOSE CYCLOPHOSPHAMIDE IN METASTATIC BREAST-CANCER
    SPICER, DV
    KELLEY, A
    HERMAN, R
    DEAN, G
    STEVENSON, L
    MITCHELL, MS
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1992, 34 (06) : 424 - 426
  • [23] 2ND LINE THERAPY WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 ALONE IN ADVANCED RENAL-CANCER PATIENTS RESISTANT TO INTERFERON-ALPHA
    LISSONI, P
    BARNI, S
    ARDIZZOIA, A
    CRISPINO, S
    PAOLOROSSI, F
    ARCHILI, C
    VAGHI, M
    TANCINI, G
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (01) : 92 - 96
  • [24] A PHASE-I STUDY OF INTERFERON-ALPHA-2B IN COMBINATION WITH INTERLEUKIN-2 IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    SCHNITTMAN, SM
    VOGEL, S
    BASELER, M
    LANE, HC
    DAVEY, RT
    JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (05): : 981 - 989
  • [25] Phase II clinical trial of low-dose interleukin-2, interferon-alpha, and low-dose tegafur uracil therapy for advanced renal cell cancer.
    Kato, Tomoyuki
    Iwamura, Masatsugu
    Fujita, Tetsuo
    Saito, Seiichi
    Ohshiro, Yoshinori
    Imai, Tomoyuki
    Kawata, Nozomu
    Tomita, Yoshihiko
    Sejima, Takehiro
    Kishida, Takeshi
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [26] SUBCUTANEOUS ADMINISTRATION OF INTERLEUKIN-2 AND INTERFERON-ALPHA-2B IN ADVANCED RENAL-CELL CARCINOMA - A CONFIRMATORY STUDY
    FACENDOLA, G
    LOCATELLI, MC
    PIZZOCARO, G
    PIVA, L
    PEGORARO, C
    PALLAVICINI, EB
    SIGNAROLDI, A
    MEREGALLI, M
    LOMBARDI, F
    BERETTA, GD
    SCANZI, F
    LABIANCA, R
    LUPORINI, G
    BRITISH JOURNAL OF CANCER, 1995, 72 (06) : 1531 - 1535
  • [27] A phase II study of interferon alpha and low-dose subcutaneous interleukin-2 in advanced renal cell carcinoma
    Piga, A
    Giordani, P
    Quattrone, A
    Giulioni, M
    DeSignoribus, G
    Antognoli, S
    Cellerino, R
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1997, 44 (06) : 348 - 351
  • [28] Immune effects of low-dose subcutaneous interleukin-2 in patients with metastatic malignant melanoma
    Demir, G
    Demirelli, F
    Özgüroglu, M
    Molinas-Mandel, N
    Büyükünal, E
    Tüzüner, N
    Serdengeçti, S
    Berkarda, B
    INTERNATIONAL JOURNAL OF IMMUNOTHERAPY, 1998, 14 (03): : 163 - 168
  • [29] IMMUNOLOGICAL EFFECTS OF A SINGLE EVENING SUBCUTANEOUS INJECTION OF LOW-DOSE INTERLEUKIN-2 IN ASSOCIATION WITH THE PINEAL HORMONE MELATONIN IN ADVANCED CANCER-PATIENTS
    LISSONI, P
    BARNI, S
    ARDIZZOIA, A
    BRIVIO, F
    TANCINI, G
    CONTI, A
    MAESTRONI, GJM
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 1992, 6 (04): : 132 - 136
  • [30] DO BONE METASTASES OF RENAL-CELL CARCINOMA RESPOND TO IMMUNOTHERAPY WITH INTERLEUKIN-2 AND INTERFERON-ALPHA-2B
    METZNER, B
    SIEGMUND, R
    KIRCHNER, H
    ATZPODIEN, J
    ILLIGER, HJ
    TUMORDIAGNOSTIK & THERAPIE, 1991, 12 (05) : 192 - 196
12345